Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Nora AI
  • Q&A
  • About Us
    • Our Coverage
    • Team
Regulatory press release

OBSRV: Observe Medical receives first UnoMeter[TM] Safeti[TM] Plus orders from key Central and South American markets, representing 75% of the historic sales in the region

Observe Medical
Oslo, July 11, 2025 - Observe Medical ("the Company" or "Observe Medical") is
pleased to announce that it has received first orders for UnoMeterT SafetiT Plus
from distributors covering Argentina and the seven Central American countries.
This comes in addition to a previous order already received from Chile.

These markets together represent approximately 75% of the Company's historic
sales in the region. With a combined population exceeding 600 million, Central
and South America offer a significant commercial opportunity, with an estimated
market potential of NOK 90-100 million in annual recurring revenue for the
UnoMeterT portfolio.

Jørgen Mann, CEO of Observe Medical, commented:

"Central and South America represent important growth markets for Observe
Medical, both geographically and financially. We are pleased to see renewed
momentum in some of the region's most promising countries, and the reactivation
of these markets is a strong endorsement of the UnoMeterT product line. With
local representation now in place, we expect to expand further into other
attractive countries across the region. So far in 2025, we have received orders
for UnoMeterT products from over 40 countries, and we remain focused on
continuing this positive global expansion"

For further information, please contact:

Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67558
E-mail: jorgen.mann@observemedical.com

Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12765
E-mail: johan.fagerli@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available atwww.observemedical.com.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.